Topic: Moderna
CAMBRIDGE, Mass. (MIT News) — Noubar Afeyan PhD ’87, an inventor and parallel entrepreneur with a penchant for bold ideas, will deliver the address at the OneMIT Commencement Ceremony on[...]
By Amy Feldman CAMBRIDGE, Mass. (Forbes) — “I constantly say things that are unreasonable and seemingly crazy,” says Noubar Afeyan, founder of venture firm Flagship Pioneering and chairman of Moderna.[...]
YEREVAN (PanARMENIAN.Net) — Norway will provide a “significant batch” of the Moderna vaccine to Armenia, newly appointed Norwegian ambassador to Yerevan Helene Sand Andresen has revealed. Andresen made the remarks[...]
CAMBRIDGE, Ma. — Moderna has no plans to share the recipe for its COVID-19 vaccine because executives have concluded that scaling up the company’s own production is the best way[...]
CAMBRIDGE, Ma. — Moderna co-founder and chairman Noubar Afeyan — an American entrepreneur of Armenian descent — has made to this year’s Forbes list of the 400 richest people in[...]
NEW YORK — Bishop Daniel Findikyan, Primate of the Eastern Diocese of the Armenian Church of America, was elected by unanimous vote to the board of directors of the Appeal[...]
By Elizabeth Cohen, John Bonifield and Jamie Gumbrecht, SAVANNAH, Ga. (CNN) — The first Phase 3 clinical trial of a coronavirus vaccine in the United States began Monday, July 27. The investigational vaccine was developed by[...]
CHICAGO (Reuters) — A study of Moderna Inc’s COVID-19 vaccine in mice lends some assurance that it will not increase the risk of more severe disease, and that one dose[...]
By Denise Grady SEATTLE (New York Times) — The first testing in humans of an experimental vaccine for the new coronavirus began on Monday, March 16, the National Institute of Allergy and[...]